ADO (ASX) Ann: Anteo Makes Solid Progress With Geneodx Partnership

Originally posted by bourbasted: ↑

Hi Dolce. I'm trying to recall a time when our IP/technology was compromised and/or reverse engineered by a previous partner/working group. Philips (aka PoC1) would be the only instance I can think of when it was a possibility, but the likelihood is low, as the POC product they actually produced had no multiplexing feature which was a key capability of M&G. Happy for you to provide other examples, but I'm failing to come up with much. Not trying to be argumentative, genuinely trying to understand where the comment came from.

The main difference I see between this arrangement and PoC1 (and other early engagements) is these are pre-made products, not customised formulas developed along side scientists from Chinese coys. Not to say that it can't be reverse-engineered (the Chinese are brilliant in this area), but I don't think they could legally do it (assuming contracts are reasonable) and I don't see us co-sharing a lab to develop with them as we did with Philips.

The structure of this agreement gives me some hope as well.  Geneodx is a Chinese company with exclusive rights to distribute Anteo products. They have a vested interest in protecting the IP. This is no longer an Aussie company dealing directly with Chinese coys as end users. This isn't to say that GeneoDX couldn't betray us, but it's a better position to be in imho.

Regardless, this is a good progress report. Will be happier when we have some commercials / predicted revenue to consider.

All IMHO, FWIW, GLTA, blah blah blah...

Expand

Hi BB and DV,

I think you make a good point, DV, but the main issue with IP and China (apart from cyber espionage) has been the insistence that an overseas company establishes a subsidiary in partnership with a Chinese-government controlled entity. That's where a more overt level of IP can be at risk.

Doesn't seem to be the same case here.

Originally posted by bourbasted: ↑

Hi Dolce. I'm trying to recall a time when our IP/technology was compromised and/or reverse engineered by a previous partner/working group. Philips (aka PoC1) would be the only instance I can think of when it was a possibility, but the likelihood is low, as the POC product they actually produced had no multiplexing feature which was a key capability of M&G. Happy for you to provide other examples, but I'm failing to come up with much. Not trying to be argumentative, genuinely trying to understand where the comment came from.

The main difference I see between this arrangement and PoC1 (and other early engagements) is these are pre-made products, not customised formulas developed along side scientists from Chinese coys. Not to say that it can't be reverse-engineered (the Chinese are brilliant in this area), but I don't think they could legally do it (assuming contracts are reasonable) and I don't see us co-sharing a lab to develop with them as we did with Philips.

The structure of this agreement gives me some hope as well.  Geneodx is a Chinese company with exclusive rights to distribute Anteo products. They have a vested interest in protecting the IP. This is no longer an Aussie company dealing directly with Chinese coys as end users. This isn't to say that GeneoDX couldn't betray us, but it's a better position to be in imho.

Regardless, this is a good progress report. Will be happier when we have some commercials / predicted revenue to consider.

All IMHO, FWIW, GLTA, blah blah blah...

Expand

No.	Vol.	Price($)
6	162089	2.6¢

No.

Vol.

Price($)

162089

2.6¢

Price($)	Vol.	No.
2.7¢	84213	1

Price($)

Vol.

No.

2.7¢

84213

No.	Vol.	Price($)
1	100045	0.017
12	5392623	0.016
6	1570373	0.015
5	1270000	0.014
2	1045000	0.013

No.

Vol.

Price($)

100045

0.017

5392623

0.016

1570373

0.015

1270000

0.014

1045000

0.013

Price($)	Vol.	No.
0.018	165394	4
0.019	555555	1
0.020	469389	4
0.021	105917	1
0.022	1013156	4

Price($)

Vol.

No.

0.018

165394

0.019

555555

0.020

469389

0.021

105917

0.022

1013156

(20min delay)
Last 2.6¢		Change -0.001(3.70%)		Mkt cap ! $54.77M

Open	High	Low	Value	Volume
2.7¢	2.7¢	2.6¢	$30.12K	1.130M

Ann: Anteo Makes Solid Progress With Geneodx Partnership, page-24

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NAB flags 8.1% cash profit drop in FY24, but says growth story is still there

ASX Market Open: ASX to rise on back of Trump Trade fever | 7 Nov 2024

Microcap Power Minerals confirms "high-grade" niobium, rare earths at Tantalo

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Buyers (Bids)

Sellers (Offers)

Ann: Anteo Makes Solid Progress With Geneodx Partnership, page-24

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NAB flags 8.1% cash profit drop in FY24, but says growth story is still there

ASX Market Open: ASX to rise on back of Trump Trade fever | 7 Nov 2024

Microcap Power Minerals confirms "high-grade" niobium, rare earths at Tantalo

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Buyers (Bids)

Sellers (Offers)